Voloridge Investment Management, LLC Amneal Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $169,690 - $313,623	50,503 New	50,503 $306,000
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $296,048 - $394,346	-57,822 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $274,076 - $426,726	57,822 New	57,822 $389,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $146,467 - $278,645	-51,034 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.46 - $5.35 $125,543 - $273,031	51,034 New	51,034 $178,000
Q4 2019 Feb 14, 2020	SELL	$2.65 - $5.56 $227,436 - $477,186	-85,825 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $5,617 - $17,416	2,453 Added 2.94%	85,825 $249,000
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $536,915 - $1.19 Million	83,372 New	83,372 $598,000

190

140M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.34B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.